Evaluation of a Disposable Flexible Bronchoscope, aScope IV
NCT02255838 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-04-26
Summary
Flexible bronchoscopes are typically reusable and therefore need high level disinfection to prevent inadvertent spread of microbial pathogens from patient to patient. The process of disinfection is time consuming and expensive. Moreover, a bronchoscope being processed may not be readily available for another patient. One solution to this problem was to use a single use disposable sheath that covers a flexible bronchoscope protecting all surfaces of the bronchoscope.(Colt, Beamis, Harrell, \& Mathur, 2000). Another way to eliminate potential hazards with a reusable bronchoscope is the use of a disposable bronchoscope. Such a disposable bronchoscope has been developed (Ambu aScope, Ambu, Glen Burnie, MD) and has been used successfully for intubations in manikins(Scutt et al., 2011) and patients. (Kristensen \& Fredensborg, 2013; Pujol, López, \& Valero, 2010; Tvede, Kristensen, \& Nyhus-Andreasen, 2012). Further advancement in the imaging and handling of this disposable flexible bronchoscope now allows for the purpose of bronchoscopy and broncho-alveolar lavage in critically ill patients with pulmonary compromise. (FDA approval: 05-11-2013 date)
The aim of the study is to compare image clarity, suction capacity, and handling performance of a reusable flexible bronchoscope to the disposable flexible bronchoscope. In addition, the investigators intend to perform a cost analysis.
Conditions
- Respiratory Insufficiency
- Pneumonia
- Atelectasis
Interventions
- DEVICE
-
Bronchoscope reusable (Storz 8402 2x)
Bronchoscopy and alveolar lavage
- DEVICE
-
Bronchoscope disposable (aScope 4)
Bronchoscopy and alveolar lavage
Sponsors & Collaborators
-
University of Louisville
lead OTHER
Principal Investigators
-
Rainer Lenhardt, MD MBA · University of Louisville School of Medicine Department of Anesthesiology and Perioperative Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-01
- Primary Completion
- 2020-01-14
- Completion
- 2020-01-14
Countries
- United States
Study Locations
More Related Trials
-
Strados System at Center of Excellence
NCT04485741 ·Status: COMPLETED
-
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
NCT01559051 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
NCT02216630 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
NCT03265145 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Different Ways for Using Lidocaine During FB
NCT06563050 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
NCT05986318 ·Status: RECRUITING ·Phase: PHASE2
-
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
NCT02276222 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution
NCT02632851 ·Status: COMPLETED
-
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
NCT03829618 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
NCT01313624 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
NCT07061925 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
NCT01857323 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02175342 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis
NCT00205647 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)
NCT01855230 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
NCT05258682 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Inhaled NAC in Treatment of IPF
NCT03720483 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888 ·Status: RECRUITING ·Phase: NA
-
Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation
NCT02172508 ·Status: TERMINATED ·Phase: PHASE4
-
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
NCT06760273 ·Status: RECRUITING
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients
NCT02315144 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
NCT03795350 ·Status: TERMINATED ·Phase: PHASE1